Embed Size (px)
Citation preview
Collateral
Corner
Global CareIndexTM: The Importance of Laboratory Data
Global CareIndexTM (GCI) provides practice management and patient action tools at the tip of your fingers. Take advantage of practice-specific reports automatically prepared on a monthly basis using prior 12 month history.
▲ Global
CareIndex™ allows the user to generate easy to read, custom reports. GCI provides graphic representations to compare and analyze laboratory results from patients tested at multiple practice locations to ensure quality, consistent patient care.
Laboratory Analytics can benefit practices in many ways:
• Improve patient care and practice operations
• Facilitate patient follow-up
• Benchmark, Track and Trend laboratory data
• Manage referrals to specialists
• Work with managed care
• Achieve pay for performance goals
Global CareIndex™ provides practices the ability to track patients who have been tested and may not have been called back for re-testing and evaluation. The practices have the ability to select particular months as well as reference range cut-off levels. The report provides a user friendly call back list to track and manage office visits of sick or at-risk patients.
Patients At Risk
Attachment 1
Practice Summary A1C > 5.6
481 Edward H. Ross DriveElmwood Park, NJ 07407T: 800-555-5555 x5555
C: 555-555-5555F: 555-555-5555
Your Name Your Title
BioReference Business Card Redesign 2015.indd 1 3/16/15 11:21 AM
481 Edward H. Ross DriveElmwood Park, NJ 07407T: 800-555-5555 x5555
C: 555-555-5555F: 555-555-5555
Your Name Your Title
GenPath WH Business Card Redesign 2015.indd 1 3/16/15 11:23 AM
481 Edward H. Ross DriveElmwood Park, NJ 07407T: 800-555-5555 x5555
M: 555-555-5555F: 555-555-5555
Your Name Your Title
Salvando Vidas, Todos Los Días
LBS Business Card Redesign 2015.indd 1 3/16/15 11:18 AM
®
o n c o l o g y
www.bioreference.com • www.genedx.com • www.genpath.com • www.laboratoriobuenasalud.com
BioReference Business Card Redesign 2015.indd 2 3/16/15 11:21 AM
®
o n c o l o g y
www.bioreference.com • www.genedx.com • www.genpath.com • www.laboratoriobuenasalud.com
GenPath WH Business Card Redesign 2015.indd 2 3/16/15 11:23 AM
®
o n c o l o g y
www.bioreference.com • www.genedx.com • www.genpath.com • www.laboratoriobuenasalud.com
LBS Business Card Redesign 2015.indd 2 3/16/15 11:18 AM
481 Edward H. Ross Drive
Elmwood Park, NJ 07407
T: 800-555-5555 x5555
C: 555-555-5555
F: 555-555-5555
www.bioreference.com
Your Name
Your Title
BioReference Business Card Redesign 2015.indd 1
3/16/15 11:21 AM
481 Edward H. Ross Drive
Elmw
ood Park, NJ 07407
T: 800-555-5555 x5555
C: 555-555-5555
F: 555-555-5555
yourname@
genpathdiagnostics.com
www.genpath.com
Your Nam
e Your Title
GenPath W
H Business C
ard Redesign 2015.indd 1
3/16/15 11:23 AM
481 Edward H. Ross Drive
Elmw
ood Park, NJ 07407T: 800-555-5555 x5555
M: 555-555-5555
F: 555-555-5555
yourname@
laboratoriobuenasalud.com
www.laboratoriobuenasalud.com
Your Nam
e Your Title
Salvando Vidas, Todos Los Días
LBS Business Card Redesign 2015.indd 1
3/16/15 11:18 AM
Global CareIndex Brochure• Provides an overview of GCI as a practice
management and patient action tool
• Highlights the power of GCI within the practice setting, including improving patient care and follow-up, tracking laboratory data, managing referrals, and more
• Includes example Practice Summary, Patient Tracking, and Analytes Charts and Reports
Marketing is excited to release new business cards for BioReference, GenPath Women’s Health, and Laboratorio Buena Salud. Using a combination of each brand’s primary design elements and colors, the new templates feature a refreshing modern look on the front, and highlight all of the BioReference business units on the back. The designs were created to show consistency and alignment within the brands, and reinforce that each individual business unit is part of something bigger.
As we transition to these new cards we are asking everyone, please DO NOT discard of your current business cards. Use up your current stock of business cards and request new ones only when they are needed. This is to help avoid mass ordering and alleviate the potential for printing and shipping delays. When you are in need of a new order, please follow the same procedure for requesting business cards through Sales Support, and we will let you know if and when the ordering process changes. Until then, we hope that you are able to leave behind a lasting impression, with our new business cards!
by Christian Marin
Leave Behind an Impression with New BusiNess Cards
For Internal Use Only-Do NOT Forward, Copy, or Distribute
March is Colorectal Cancer Awareness Month, a time dedicated to spreading awareness and prevention of cancer of the colon or
rectum. With screening, and if detected early, it can be prevented or more easily treated than any other cancer.
Did you know:
• Colon cancer is the third most commonly diagnosed cancer and the second leading cause of cancer death in men and women combined in the US.
• Colorectal cancer is as common in women as it is in men.
• On average, the lifetime risk of developing colon cancer is about one in 20, however, this varies widely according to individual risk factors.
• About 72% of cases arise in the colon and about 28% in the rectum.
Screening Saves:
• Despite its high incidence, colon cancer is unique in that it is one of the most preventable and, if found early, most treatable forms of cancer.
• Over 90% of those diagnosed when the cancer is found at a local stage (confined to colon or rectum) survive more than five years.
• Studies have proven that the Fecal Occult Blood Test (FOBT), when performed every 1 to 2 years in people ages 50 to 80, reduces the number of deaths due to colorectal cancer by as much as 30%.
Now is the time to talk with your clients about the importance of screening using our FOBT. To help guide you with these conversations, collateral material for colorectal cancer is available on Pick Pack. Additional resources and information can be found by visiting The Colon Cancer Alliance.
By Katie Peterson
Colorectal Cancer Awareness Month
Teams from the Sales and Marketing office in Elmwood Park partici-pate in National Dress in Blue Day to support Colon Cancer Awareness
As the healthcare landscape shifts toward larger group practices, and implementation of the Affordable Care Act (ACA) continues to shift the healthcare model to that of the Accountable Care Organization (ACO), BioReference will have to be more nimble and creative than ever to capture this business.
Early success has been achieved in South Florida, as BioReference is now the Preferred Laboratory for PremierMD. It has taken a true team effort from our Florida Clinical Sales team to bring the PremierMD/BioReference partnership to fruition. Kudos to you all!
To help with this partnership we were able to leverage our Global CareIndex system, which is regularly adding attractive features to provide ACOs with important analytical information that help them achieve pay for performance goals, keep downstream costs contained and offer their patients a higher level of care. In order to tie the various physician specialties within the PremierMD network together, especially for those patients with more than one illness, our dedicated Care Coordinator is an invaluable resource for PremierMD.
BioReference is in a great position to continue to attack the ACO market, especially as we expand our clinical operations into new markets. Our physician driven sales model is a perfect fit for those ACOs formed and owned by physicians (as opposed to hospital networks). As the healthcare market changes, BioReference must be willing to adapt to new market forces. The partnership between PremierMD and BioReference is a great first step.
About PremireMD:
• Physician owned and operated ACO
• Based in Ft. Lauderdale
• More than 300 physicians in the network
by David Spector
Now Premiering: A New ACO Partnership in Florida
With much anticipation, we are pleased to announce GenPath Women’s Health and Oncology are contributing to the evolution of science by now offering a full suite of inherited cancer (IC) genetic testing panels. To make this offering possible, GenPath joined forces with GeneDx, our sister laboratory that
specializes in the genetic testing of rare hereditary disorders.
About IC Testing (Commentary from Sherri Bale, Ph.D., founder and the Managing Director of GeneDx):
• Our IC testing and panels will provide an efficient and cost effective approach to identifying the genetic basis of inherited cancer. For breast/ovarian cancer particularly, it will be a more sensitive approach than testing only the BRCA1 and BRCA2 genes alone.
• Over the past decade, research has identified many genes associated with hereditary cancers. Some of these genes play a role in more than one type of cancer, and in most types of cancer several genes may be characterized as causative. Determining which genes and the order in which to test them can be complex, expensive and time consuming.
• GeneDx, has developed comprehensive panels to facilitate testing of all the important genes associated with inherited cancers in a manner that provides rapid and accurate results and at typically no additional cost when compared to testing for a single gene.
With these developments and offerings, GenPath is confident in successfully breaking into the IC testing market. Moving forward, we hope to spread awareness to individuals and family members who may have a concerning history regarding inherited cancers, and continue to discover groundbreaking findings that may lead to end Cancer’s diagnostic odyssey.
GenPath Launches Inherited Cancer Genetic Testing
By Elisabeth Scaffidi
In February, the Women’s Health and Oncology sales teams joined together in Nasheville for a very informative (and eventful) 2-day training program to learn about IC testing. This training covered topics such as:
• Handling external stakeholders questions about the tests
• Comparing competitive offerings based on importance, price, and turn-around time
• Discussing the quality of the results, including the variant of-unknown-significance (VUS) rates
In an effort to drive home our messaging and reinforce key concepts covered during the initial training, Sales and Marketing developed a brief online learning series, and conducted twice-weekly classes throughout March. Topics included: Requisition Review, Panels & Billing Basics, Balancing the Portfolio, and a Competitive Overview. We concluded the series with an optional scientific session featuring Kristen Postula, who is one of our many talented genetic counselors on staff. Over fifty people joined the call, which truly showed everyone’s enthusiasm to learn more about this fascinating subject. For those of you who are still thirsty for knowledge, you can look forward to additional reinforcement and training sessions at this year’s National Sales Meeting!
The More You KnowBy Jami Kaliebe
Physicians are now, more so than ever, choosing to enhance their digital footprint via social media platforms. With nearly one-third of patients using social media sites for health-related matters, there is an opportunity for physicians to not only market their practice and connect with patients, but also to stay in touch with peers and share educational information.
With an increase in overall physician and patient activity online, the Sales and Marketing team sees great value in expanding our online presence, and we have revamped our approach to using social media as a means for patient education and client interaction.
We are pleased to introduce Erika E., our new marketing intern, whom will focus the majority of her time with us on growing our social media channels. Erika brings a fresh and enthusiastic perspective on social media and online branding, and we are excited to have her join us. Ericka has already started engaging in various online conversations and posting multiple messages per day, and is also doing her due diligence finding our clients online as a means to increasing interaction. Since she began last month, we’ve already seen a 155% increase in followers on the Women’s Health twitter account.
You can follow BioReference Clinical on Facebook, LinkedIn, and now Twitter, and you can find GenPath Women’s Health on Facebook and Twitter.
New Sizzle on SocialBy Katie Peterson
In a recent study, ZocDoc reported that nearly 87% of physicians age 26-55 use social media, and 65% of physicians age 56-75 use social media (of those surveyed).
Patricia NeyboldDirector of Core Laboratory Operations
Quality. There is nothing more important to Director of Core Laboratory Operations Patricia
(Patti) Neybold. Since making the transition to BioReference when it purchased MediLabs in 1998, Patti has played a major role in making the BioReference clinical lab synonymous with quality.
A lifelong New York resident with ancestry from Spain and Costa Rica, Patti was born in Brooklyn and at a young age moved to Orange County, where she still lives with her husband and two teenage children.
The clinical lab operates 24 hours a day, 7 days a week, and all together Patti manages a team of more than 175 people, whom are all dedicated to ensuring BioReference clients get the most accurate results for their patients. This requires near constant maintenance. The lab equipment is subject to Quality Control measures each shift, three times a day. “Our number one priority is that we produce quality results before they are released,” Patti says.
Part of staying in the forefront of the clinical laboratory industry is making sure the equipment is state-of-the-art. Patti routinely evaluates equipment to make sure BioReference has the latest technology operating in the lab, and meets with vendors to discuss the latest technology and optimize the lab’s ability to automate.
At times, life in the lab can get a little monotonous, so to keep things fun and light, Patti and her team began naming new lab equipment after NFL teams. Herself a huge fan of the New York Giants, it goes without saying some of your clients’ specimens are being run on a machine named after her favorite team. As BioReference has expanded its operations to remote labs outside the region, it’s only logical that among other teams represented in the lab are the San Francisco 49ers, Miami Dolphins and Houston Texans. As more machines come in and assume the names of NFL teams, there is one rule written in stone—one which Patti is not willing to negotiate: in the lab, there will never reside a piece of equipment named after the New England Patriots or Dallas Cowboys.
An important part of Patti’s duties at BioReference include working with the remote labs that have been folded into the BioReference network. She spent extensive time at all of our new locations as an integral part of their conversion. In order to use one test code company-wide—from coast to coast—Patti is responsible for implementing the same testing platforms used in Elmwood Park. Not only does this allow the use of one code, but it standardizes reference ranges from location to location, making BioReference a true nationwide full service laboratory.
It takes a small army in all departments to make BioReference run smoothly, and Patti and her team are an invaluable asset and an essential spoke in the wheel that makes BioReference run. So, if you don’t run into Patti watching her beloved New York Mets at Citi Field, the next time you are in Elmwood Park, stop by and thank Patti and her team for all they do to make BioReference the quality lab it is.
by David Spector
The Times www.bioreference.com
Better Healthcare through Better Service & Better Science
facebook twitter linkedin March 2015Volume 2 Edition 3
For Internal Use Onlywww.genpathdiagnostics.com
facebook twitter
